News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Yazan Madanat: Our research team at the Texas Blood Cancer Conference 2024
Photo from Yazan Madanat/X
May 22, 2024, 07:29

Yazan Madanat: Our research team at the Texas Blood Cancer Conference 2024

Yazan Madanat, Leukemia Director and Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, posted on X/Twitter:

“So PROUD of our research team for having a booth for patients at the Texas Blood Cancer Conference 2024! Thank you The Leukemia and Lymphoma Society and The Leukemia and Lymphoma Society Research for this wonderful meeting!”

Image

Source: Yazan Madanat/X

cancer OncoDaily Oncology TBCC2024 Texas Blood Cancer Conference 2024 The Leukemia and Lymphoma Society The Leukemia and Lymphoma Society Research UT Southwestern Medical Center Yazan Madanat
Special Coverage
Blog
Mar 27, 2025, 08:28
Apply for a Free Registration to the EACR 2025 Women in Leadership Workshop
Insight
Mar 27, 2025, 08:26
Aakash Desai: Oncology dealmakers seek multi-indication therapies
Career
Mar 27, 2025, 08:09
Manchester Cancer Research Centre is hiring Head of Strategic Partnerships and Operations
Immune Oncology
Mar 27, 2025, 08:07
Immunotherapy for Rectal Cancer: Types, Success Rate, Side Effects and More
Blog
Mar 27, 2025, 08:00
OHMX.bio joins BRECISE to revolutionize prostate and bladder cancer diagnostics
Career
Mar 27, 2025, 07:45
Join the Care Wheels Program: Medicaid Cancer Foundation
Blog
Mar 27, 2025, 07:40
Peter Pisters: An exceptional day at ACHE Congress
Blog
Mar 27, 2025, 07:40
Issue four of The Christie International Fellowship Program Newsletter is now available - Manchester Cancer Research Centre
Drugs
Mar 27, 2025, 07:38
Tucatinib (Tukysa): What patients need to know?
Insight
Mar 27, 2025, 07:26
Bobby Koneru: Three Randomized Controlled Trials (RCTs) for LDRT in Knee Osteoarthritis
Drugs
Mar 27, 2025, 07:24
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis - Mount Sinai Department of Medicine
Blog
Mar 27, 2025, 07:15
Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy